NEUROVANT Trademark

Trademark Overview

On Tuesday, July 17, 2018, a trademark application was filed for NEUROVANT with the United States Patent and Trademark Office. The USPTO has given the NEUROVANT trademark a serial number of 79243692. The federal status of this trademark filing is REGISTERED as of Tuesday, April 28, 2020. This trademark is owned by Roivant Sciences GmbH. The NEUROVANT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing health and medical information; providing information relating to pharmaceutical preparations and biologic preparations regarding prophylactic, therapeutic or diagnostic uses for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
neurovant

General Information

Serial Number79243692
Word MarkNEUROVANT
Filing DateTuesday, July 17, 2018
Status700 - REGISTERED
Status DateTuesday, April 28, 2020
Registration Number6039107
Registration DateTuesday, April 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements

Goods and ServicesProviding health and medical information; providing information relating to pharmaceutical preparations and biologic preparations regarding prophylactic, therapeutic or diagnostic uses for the prevention and treatment of diseases, disorders and conditions
Goods and ServicesScientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRoivant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressCH
Party NameRoivant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressCH
Party NameRoivant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, October 30, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 25, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, December 27, 2018NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, October 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 2, 2018ASSIGNED TO EXAMINER
Tuesday, November 6, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, November 7, 2018NON-FINAL ACTION WRITTEN
Thursday, November 8, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 21, 2018REFUSAL PROCESSED BY MPU
Wednesday, November 21, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 8, 2018REFUSAL PROCESSED BY IB
Wednesday, December 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 11, 2019FINAL REFUSAL WRITTEN
Tuesday, June 11, 2019FINAL REFUSAL E-MAILED
Tuesday, June 11, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 22, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 25, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 28, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 28, 2020FINAL DISPOSITION PROCESSED
Friday, February 7, 2020NOTIFICATION PROCESSED BY IB
Wednesday, March 25, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, April 10, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sunday, September 6, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, September 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 28, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 11, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

neurovant research pharmaceutical preparations scientific information providing pharmaceuticals therapeutic services biomedicine